Ting Liu, MD

Professor, University of Utah School of Medicine

Specialties

• Sarcoma
• Genitourinary Pathology

Education

• Master’s Degree—Pathophysiology, Peking Union Medical College
• Residency—Anatomic and Clinical Pathology, Drexel University College of Medicine
• Fellowship—Hematopathology, Drexel University College of Medicine
• Fellowship—Oncologic Surgical Pathology, Memorial Sloan-Kettering Cancer Center

Certification/Affiliations

• American Board of Pathology

Research Interests

• Translational oncologic research focus on GU and bone/soft tissue pathology

Awards

• Outstanding Teaching Award in Anatomic Pathology, 2015
• Outstanding Teaching Award in Anatomic Pathology, 2009

Recent Publications

• Maughan BL, Pal SK, Gill D, et al. Modulation of premetastatic niche by the vascular endothelial growth factor receptor tyrosine kinase inhibitor pazopanib in localized high-risk prostate cancer followed by radical prostatectomy: a phase ii randomized trial. Oncologist. 2018;23(12):1413-e151.
• Gupta S, Albertson D, Gaston D, et al. Comprehensive genomic sequencing of urothelial tumors identifies rare SMARCB1 (INI-1)-deficient carcinomas of the urinary system. Clin Genitourin Cancer. 2018;16(2):e373-e382.
• Lewis AJ, Dhakal BK, Liu T, et al. Histone deacetylase 6 regulates bladder architecture and host susceptibility to uropathogenic Escherichia coli. Pathogens. 2016;5(1):20.
• Barrott JJ, Kafchinski LA, Jin H, et al. Modeling synovial sarcoma metastasis in the mouse: PI3'-lipid signaling and inflammation. J Exp Med. 2016;213(13):2989-3005.